FDA Approves Trabectedin for Two Soft Tissue SarcomasFDA Approves Trabectedin for Two Soft Tissue Sarcomas

Researchers saw no improvement in overall survival in the pivotal US trial, but there are explanations for that. FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news